Tag: generic drug patents

Patent litigation in generic drug markets is delaying affordable medicines by years. With serial lawsuits, improper patent listings, and complex settlements, patients pay billions more than they should. Here’s how the system works - and why it’s broken.

Tentative FDA approval for generics means the drug meets all safety and quality standards - but it still can't be sold. Learn why patents, lawsuits, manufacturing issues, and corporate strategy cause long delays before generics reach patients.